Evidence map›Paper›PMID 24947364›Full record

ArticleDiabetes2014

Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity.

Robert A Scott, Tove Fall, Dorota Pasko, Adam Barker, Stephen J Sharp, Larraitz Arriola, Beverley Balkau, Aurelio Barricarte, Inês Barroso, Heiner Boeing and 45 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04040595 (The Genetics of Adipose Tissue Function and Its Link to Type 2 Diabetes and Heart Disease), which is not on this map. Cited by 110 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 7 pooled it
13.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04040595 nacompletednot on this mapstarted 2019, after this paper: background citation

The Genetics of Adipose Tissue Function and Its Link to Type 2 Diabetes and Heart Disease

TypeinterventionalSponsorRoyal Devon and Exeter NHS Foundation TrustRan2019 to 2021Enrolled207ConditionsDiabetes MellitusArmsAbdominal fat biopsy
3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 7 syntheses or guidelines pooled it, 173 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. The Association Between SerumInternational journal of endocrinology · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Heterogeneity of type 2 diabetes in rural India.Frontiers in endocrinology · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

55 authors at 20 institutions in 10 countries.

Robert A ScottMRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Tove FallDepartment of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Dorota PaskoGenetics of Complex Traits, University of Exeter Medical School, Exeter, UK.
Adam BarkerMRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Stephen J SharpMRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Larraitz ArriolaPublic Health Division of Gipuzkoa, San Sebastian, Spain.
Beverley BalkauInserm, CESP, U1018, Villejuif, France.
Aurelio BarricarteNavarre Public Health Institute (ISPN), Pamplona, Spain.
Inês BarrosoThe Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
Heiner BoeingGerman Institute of Human Nutrition Potsdam-Rehbruecke, Germany.
Françoise Clavel-ChapelonInserm, CESP, U1018, Villejuif, France.
Francesca L CroweUniversity of Oxford, United Kingdom.
Jacqueline M DekkerDepartment of Epidemiology and Biostatistics, VrijeUniversiteit Medical Center, Amsterdam, The Netherlands.
Guy FagherazziInserm, CESP, U1018, Villejuif, France.
Ele FerranniniDepartment of Internal Medicine, University of Pisa, Pisa, Italy.
Nita G ForouhiMRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Paul W FranksLund University, Malmö, Sweden.
Diana GavrilaDepartment of Epidemiology, Murcia Regional Health Council, Murcia, Spain.
Vilmantas GiedraitisDepartment of Public Health and Caring Sciences, Geriatrics, Uppsala University Sweden.
Sara GrioniEpidemiology and Prevention Unit, Milan, Italy.
Leif C GroopUniversity Hospital Scania, Malmö, Sweden.
Rudolf KaaksGerman Cancer Research Centre (DKFZ), Heidelberg, Germany.
Timothy J KeyUniversity of Oxford, United Kingdom.
Tilman KühnGerman Cancer Research Centre (DKFZ), Heidelberg, Germany.
Luca A LottaMRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Peter M NilssonLund University, Malmö, Sweden.
Kim OvervadDepartment of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
Domenico PalliCancer Research and Prevention Institute (ISPO), Florence, Italy.
Salvatore PanicoDipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
J Ramón QuirósPublic Health Directorate, Asturias, Spain.
Olov RolandssonUmeå University, Umeå, Sweden.
Nina RoswallDanish Cancer Society Research Center, Copenhagen, Denmark.
Carlotta SacerdoteUnit of Cancer Epidemiology, Citta' della Salute e della Scienza Hospital-University of Turin and Center for Cancer Prevention (CPO), Torino, Italy.
Núria SalaUnit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Program, and Translational Research Laboratory, Catalan Institute of Oncology (IDIBELL), Barcelona, Spain.
María-José SánchezAndalusian School of Public Health, Granada, Spain.
Matthias B SchulzeGerman Institute of Human Nutrition Potsdam-Rehbruecke, Germany.
Afshan SiddiqSchool of Public Health, Imperial College London, UK.
Nadia SlimaniInternational Agency for Research on Cancer, Lyon, France.
Ivonne SluijsUniversity Medical Center Utrecht, Utrecht, the Netherlands.
Annemieke Mw SpijkermanNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Anne TjonnelandDanish Cancer Society Research Center, Copenhagen, Denmark.
Rosario TuminoASP Ragusa, Italy.
Daphne L van der ANational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Hanieh YaghootkarGenetics of Complex Traits, University of Exeter Medical School, Exeter, UK.
RISC study group
EPIC-InterAct consortium
Mark I McCarthyOxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), University of Oxford, UK.
Robert K SempleUniversity of Cambridge Metabolic Research Laboratories, Cambridge, UK.
Elio RiboliSchool of Public Health, Imperial College London, UK.
Mark WalkerInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Erik IngelssonDepartment of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Tim M FraylingGenetics of Complex Traits, University of Exeter Medical School, Exeter, UK.
David B SavageUniversity of Cambridge Metabolic Research Laboratories, Cambridge, UK.
Claudia Langenberg *MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Nicholas J Wareham *MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
MRC Epidemiology Unit · GBUppsala University · SEUniversité Paris-Sud · FRUniversity of Cambridge · GBUniversity of Exeter · GBCentre for Human Genetics · GBCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESDanish Cancer Society · DKGerman Cancer Research Center · DEGerman Institute of Human Nutrition · DEImperial College London · GBLund University · SENational Institute for Public Health and the Environment · NLUniversity of Oxford · GBAarhus University · DKAgenzia Regionale Sanitaria della Puglia · ITBasque Government · ESCentre international de recherche sur le cancer · FRFederico II University Hospital · ITGobierno del Principado de Asturias · ES

Funding

Cancer Research UK 16491Medical Research Council G0500070Medical Research Council G0600717Medical Research Council G0601261Medical Research Council G0701863Medical Research Council MC_U106179471Medical Research Council MC_UP_A100_1003Medical Research Council MC_UU_12012/5Medical Research Council MC_UU_12015/1Medical Research Council MC_UU_12015/5Wellcome Trust 083270/Z/07/ZWellcome Trust 091551Wellcome Trust 098051Wellcome Trust 098381Wellcome Trust 098498Wellcome Trust 100574World Health Organization 001
6 · The paper itself

Abstract

We aimed to validate genetic variants as instruments for insulin resistance and secretion, to characterize their association with intermediate phenotypes, and to investigate their role in type 2 diabetes (T2D) risk among normal-weight, overweight, and obese individuals. We investigated the association of genetic scores with euglycemic-hyperinsulinemic clamp- and oral glucose tolerance test-based measures of insulin resistance and secretion and a range of metabolic measures in up to 18,565 individuals. We also studied their association with T2D risk among normal-weight, overweight, and obese individuals in up to 8,124 incident T2D cases. The insulin resistance score was associated with lower insulin sensitivity measured by M/I value (β in SDs per allele [95% CI], -0.03 [-0.04, -0.01]; P = 0.004). This score was associated with lower BMI (-0.01 [-0.01, -0.0]; P = 0.02) and gluteofemoral fat mass (-0.03 [-0.05, -0.02; P = 1.4 × 10(-6)) and with higher alanine transaminase (0.02 [0.01, 0.03]; P = 0.002) and γ-glutamyl transferase (0.02 [0.01, 0.03]; P = 0.001). While the secretion score had a stronger association with T2D in leaner individuals (Pinteraction = 0.001), we saw no difference in the association of the insulin resistance score with T2D among BMI or waist strata (Pinteraction > 0.31). While insulin resistance is often considered secondary to obesity, the association of the insulin resistance score with lower BMI and adiposity and with incident T2D even among individuals of normal weight highlights the role of insulin resistance and ectopic fat distribution in T2D, independently of body size.

Indexed as

AdultAgedAlanine TransaminaseBody CompositionBody Fat DistributionBody Mass IndexCohort StudiesDiabetes Mellitus, Type 2Femalegamma-GlutamyltransferaseGenetic Predisposition to DiseaseGenetic VariationGlucose Clamp TechniqueGlucose Tolerance TestHumansInsulinAlanine Transaminasegamma-GlutamyltransferaseInsulin

Identifiers

PMID24947364
PMCPMC4241116
OpenAlexW2127294907

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.